BALVERSA®
(erdafitinib)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
BALVERSA® (erdafitinib)
Medical Information
BALVERSA – Specialty Pharmacy and Specialty Distributors
Last Updated: 01/23/2025
BACKGROUND
- BALVERSA®
(erdafitinib) is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC) with susceptible FGFR3 genetic alterations whose disease has progressed on or after at least one line of prior systemic therapy.1 - Select patients for therapy based on an FDA-approved companion diagnostic for BALVERSA.
- Limitations of Use: BALVERSA is not recommended for the treatment of patients who are eligible for and have not received prior PD-1 or PD-L1 inhibitor therapy.
Accessing BALVERSA through Specialty distributors
- Access to BALVERSA is restricted to distribution via the following Specialty Distributors: ASD Healthcare and Oncology Supply.
- Please contact ASD Healthcare or Oncology Supply directly for further inquiries related to accessing BALVERSA.
Specialty Distributor Contact Information2
| Specialty Distributor | Phone | Fax | Email | Website |
|---|---|---|---|---|
| ASD Healthcare | 800-746-6273 | 800-547-9413 | [email protected] | www.ASDHealthcare.com |
| Oncology Supply | 800-633-7555 | 800-248-8205 | [email protected] | www.oncologysupply.com |
Accessing BALVERSA through a Specialty Pharmacy
- Johnson & Johnson offers BALVERSA access and patient services through CVS Specialty®. Please contact CVS Specialty directly for further inquiries related to accessing BALVERSA.
CVS Specialty Contact Information3
| Specialty Pharmacy | Phone | Fax | Website |
|---|---|---|---|
| CVS Specialty | 1-855-539-4712 | 1-888-435-1256 | www.CVSSpecialty.com |
References
| 1 | BALVERSA (erdafitinib) [Prescribing Information]. Horsham, PA: Janssen Products, LP;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/BALVERSA-pi.pdf |
| 2 | |
| 3 |